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Abstract: African trypanosomiasis or sleeping sickness is a zoonotic disease caused by Trypanosoma
brucei, a protozoan parasite transmitted by Glossina spp. (tsetse fly). Parasite introduction into mam-
mal hosts triggers a succession of events, involving both innate and adaptive immunity. Macrophages
(MΦ) have a key role in innate defence since they are antigen-presenting cells and have a micro-
bicidal function essential for trypanosome clearance. Adaptive immune defence is carried out by
lymphocytes, especially by T cells that promote an integrated immune response. Like mammal cells,
T. b. brucei parasites release extracellular vesicles (TbEVs), which carry macromolecules that can be
transferred to host cells, transmitting biological information able to manipulate cell immune response.
However, the exact role of TbEVs in host immune response remains poorly understood. Thus, the cur-
rent study examined the effect elicited by TbEVs on MΦ and T lymphocytes. A combined approach
of microscopy, nanoparticle tracking analysis, multiparametric flow cytometry, colourimetric assays
and detailed statistical analyses were used to evaluate the influence of TbEVs in mouse mononuclear
cells. It was shown that TbEVs can establish direct communication with cells of innate and adaptative
immunity. TbEVs induce the differentiation of both M1- and M2-MΦ and elicit the expansion of
MHCI+, MHCII+ and MHCI+MHCII+ MΦ subpopulations. In T lymphocytes, TbEVs drive the
overexpression of cell-surface CD3 and the nuclear factor FoxP3, which lead to the differentiation of
regulatory CD4+ and CD8+ T cells. Moreover, this study indicates that T. b. brucei and TbEVs seem
to display opposite but complementary effects in the host, establishing a balance between parasite
growth and controlled immune response, at least during the early phase of infection.
Keywords: African trypanosomiasis; Trypanosoma brucei brucei; exosomes; macrophages; T lympho-
cytes; regulatory T cells
1. Introduction
African trypanosomiasis (AT), also known as sleeping sickness in humans and Nagana
in cattle, is a vector-borne disease caused by an extracellular kinetoplastida parasite of
the Trypanosomatidae family, genus Trypanosoma, and species Trypanosoma brucei, which
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is transmitted by the hematophagous dipteran Glossina spp. (tsetse fly). This parasitosis
is considered a neglected tropical disease restricted to the intertropical region of Africa
following the geographical distribution of its vector. Parasite transmission to mammals
occurs by the inoculation of metacyclic trypomastigotes forms during the insect blood meal.
After being introduced into the host dermis, parasites start to replicate, giving origin
to the initial lesion or the inoculation chancre [1,2]. After two or three weeks, the chancre
tends to disappear, and the disease can evolve in two distinct successive phases [2]: Phase
I or the hemolymphatic stage is characterized by successive waves of invasion of the blood
and lymphatic system by trypanosomes, which causes intermittent fever [2,3] and phase II
or meningoencephalitis stage, where the typical symptoms of sleeping sickness (dementia,
cachexia, coma, and death) may become evident [2–4]. Trypanosome parasites have a dense
surface coat constituted by the variant surface glycoprotein (VSG). These immunogenic
coats present at the cell surface as homodimers and anchored in the membrane through gly-
cosylphosphatidylinositol constitute the pathogen-associated molecular patterns (PAMPs)
that are recognized by pattern-recognition receptors (PPRs) of innate immunity [2,4].
The innate immune response includes macrophages (MΦ), which can engulf foreign
antigens through endocytosis. When soluble parasite factors and VSG interacts with
MΦ, they became classically activated (M1-MΦ) and synthesize reactive oxygen inter-
mediates (ROI), produce nitric oxide (NO), and release proinflammatory cytokines, as is
the case of tumor necrosis factor (TNF)-α and interleukin (IL)-6 (type I cytokines) [2,5].
To reduce inflammation, trypanosome blood forms release some components, such as
Trypanosoma brucei-derived kinesin-heavy chain (TbKHC-1) and adenylate cyclase (ADC),
which upregulate the IL-10 production that prevents TNF−α expression [6,7], leading to the
differentiation of alternative activate MΦ (M2-MΦ) and production of anti-inflammatory
cytokines [5]. The inflammatory response is critical for parasite control in the early stage
of infection [5] and the switch from M1-MΦ to M2-MΦ seems to occur four weeks after
infection when the patient is in the late stage of disease [8].
Together with dendritic cells, MΦ are antigen-presenting cells (APC), establishing
a bridge with adaptive immunity. Parasite antigens complexed with class I molecules
of major histocompatibility complex (MHCI) are presented to CD8+ T cells and parasite
antigen bound to class II molecules of major histocompatibility (MHCII) complex are
recognized by CD4+ T cells. Both CD4+ and CD8+ T cells are crucial in the orchestration
of host adaptive immune response against T. b. brucei parasites. However, the successive
peaks of parasitemia exhibiting specific VSG induce a continuous activation of T cell clones,
which leads to cell exhaustion and then to immunosuppression, and consequently impaired
parasite control [9].
Like mammal cells, trypanosomes also secrete extracellular vesicles (EV), which
comprise nanovesicles that differ in size and carry parasite molecular components, such as
proteins, lipids, and nucleic acids [10]. The parasite T. brucei releases EV (TbEVs) that seems
to play a role in both parasite-parasite and parasite-host interactions, influencing host
immune response [11]. Moreover, TbEVs appear to incorporate different flagellar proteins,
acting like virulence factors, and be highly enriched in oligomers, such as tetraspanins (a
broadly expressed superfamily of transmembrane glycoproteins), known to be involved
in antigen presentation, T cell signalization and activation, and in MHCI and MHCII
generation. Also, it was demonstrated that upon fusion with erythrocytes, these TbEVs are
responsible for the removal of red cells from the host bloodstream [12].
For parasite survival in the mammal host and success in being transmitted to the
insect vector, ensuring the completion of the T. brucei life cycle, the infected host must
develop a balanced immune response able to prevent the host killing and allow parasite
replication. Despite all the studies done to understand the immune mechanisms associated
with this parasitic disease, the exact role played by TbEVs in host immune response is still
evasive. Thus, this work explores the effect of TbEVs in the immune activation of mouse
mononuclear cells.
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2. Materials and Methods
2.1. Experimental Design
To explore the effect of TbEVs on host immune response an experimental design
comprising three main steps was established. The first step aims to examine the shape,
size, and density of purified TbEVs using electron microscopy and nanoparticle tracking
analysis. In the second step, the aim was to investigate the innate activity of MΦ when
stimulated by TbEVs, including their microbicide and antigenic presentation potential, and
the last goal step aims to assess the differentiation of T cell subsets related to effector and
regulatory adaptive immune response.
Mouse MΦ-like cells were exposed to T. b. brucei trypomastigotes and stimulated by
TbEVS and BALB/c mice peripheral blood mononuclear cells (PBMC) were exposed to
T. b. brucei trypomastigotes and stimulated by TbEVS and parasite antigen (Ag). Type I
and type II MΦ activity was analyzed by NO and urea production using colourimetric
assays. The potential of MΦ to present parasite antigens to lymphocytes was indirectly
evaluated by the expression and density of surface molecules MHCI and MHCII by flow
cytometry. T lymphocyte subsets were immunophenotyped by flow cytometry through
surface expression and density of CD3 and CD25 molecules and intracellular expression
of FoxP3. In parallel, resting cells, MΦ stimulate by phorbol myristate acetate (PMA) and
PBMC stimulated by concanavalin A (ConA) were also evaluated. Furthermore, obtained
data were subject to statistical procedures.
2.2. BALB/c Mice
Six to eight-week-old male BALB/c Mus musculus mice were purchased from the
Instituto Gulbenkian de Ciências (IGC, Lisbon, Portugal) and maintained in the IHMT
animal facility, in sterile cabinets with sterile food and water ad libitum. Mice were used
to recover Trypanosome blood forms and to isolate PBMC. The animals were handled ac-
cording to the Portuguese National Authority for Animal Health (Ref. 0421/000/000/2020,
23 September 2020, DGAV—Direção Geral de Alimentação e Veterinária), in conformity
with the institutional guidelines and the experiments performed in compliance with Por-
tuguese law (Decree-Law 113/2013), EU requirements (2010/63/EU), and following the
recommendations of the Federation of European Laboratory Animal Science Associations
(FELASA).
2.3. Trypanosoma brucei brucei Parasites
Peripheral blood of BALB/c mice infected with T. brucei brucei strain G.V.R. 35 was col-
lected (Supplementary Videos S1 and S2) and treated with ammonium-chloride-potassium
lysis buffer. Trypanosoma blood forms were then purified using diethyl aminoethyl (DEAE)-
cellulose columns [13] and maintained in Schneider Drosophila medium (Sigma-Aldrich,
Hamburg, Germany) supplemented with 10% (v/v) of heat-inactivated fetal bovine serum
(hiFBS) free of extracellular vesicles (FBS-exofree, Thermo Fisher Scientific, Waltham, MA,
USA) at 24 ◦C. Parasite morphology and motility were checked every day by direct mi-
croscopy and, parasite topography was evaluated by scanning electron microscopy (SEM,
SEM-UR- LBDB Hitachi SU8010 High-Technologies Corporation, Ibaraki, Japan). TbEVs
were purified from the supernatant of cultures exhibiting motile trypomastigotes.
2.4. T. b. brucei Extracellular Nanovesicles and Parasite Crude Antigen
Trypomastigotes harvested from cultures by centrifugation at 2000× g for 10 min at
4 ◦C were used to produce parasite antigen (Ag), and TbEVs were obtained from culture
supernatants. Parasites were washed twice in phosphate-buffered saline (PBS) 2 mM
ethylenediaminetetraacetic acid (EDTA), resuspended in PBS, and then disrupted by eight
freeze-thawing cycles ranging from −20 ◦C to room temperature. After centrifugation,
protein content (mg·mL−1) was determined using a Nanodrop 1000 spectrophotometer
(Thermo Scientific, Waltham, MA, USA), and Ag was preserved at −20 ◦C. Supernatants
of trypomastigote culture incubated for 48 h were filtered through 0.2 mm syringe filters
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(VWR International, Radnor, PE, USA), and TbEVs were purified using Exosome Spin
Columns (Invitrogen, Waltham, MA, USA) according to the manufacturer’s instructions.
Isolated TbEVs were examined by SEM, single particle size and concentration analyzed by
Nanoparticle Tracking Analysis (NanoSight NTA 3.2), and protein content was estimated
by spectrophotometry.
2.5. Morphology of T. b. brucei and Parasite Extracellular Vesicles
Cultured T. b. brucei parasites deposited on glass slides were observed under an optical
microscope to evaluate parasite motility and morphology. The topography of TbEVs and
morphology of cultured-derived parasites were examined by SEM.
Round glass coverslips were immerged into poly-D-lysine (Sigma-Aldrich, Burlington,
MA, USA) overnight to increase adherence and later placed in a 24-well plate. Then para-
sites were allowed to adhere to the coverslips and were fixed with PBS 4% paraformalde-
hyde (Merck, Rahway, NJ, USA) for 30 min at 4 ◦C. Coverslips were rinsed three times with
distilled water, treated with 0.5% osmium tetroxide (Sigma-Aldrich), and washed again.
Then, plates were incubated with a fixative solution of 1% tannic acid (Sigma-Aldrich)
for 30 min. TbEVs were fixed to coverslips with 2.5% glutaraldehyde, 0.1 M sodium ca-
codylate buffer, pH 7.4 for 2 h at 4 ◦C. Afterwards, both parasites- and TbEV-coverslips
were washed and then dehydrated by sequential addition of 30%, 50%, 70%, 80%, and 90%
ethanol for 5 min each. Coverslips were immersed in 100% ethanol and then treated with
hexamethyldisilazane solvent (Sigma-Aldrich), coated with gold-palladium, mounted on
stubs to be observed under an ultra-high resolution scanning electron microscope. The
surface area and perimeter of TbEVs were quantified from acquired images using Image
J software.
2.6. Macrophage Cell Line and Primary Mononuclear Cells
PMBC were isolated from healthy (non-infected) BALB/c mice by density gradi-
ent [14]. Briefly, cells at Hystopaque-1077 (Sigma-Aldrich) and plasma interface were
removed and washed three times in PBS by centrifugation at 370× g for 10 min at 4 ◦C.
Then, the supernatant was discarded and the PMBC-containing pellet resuspended in PBS.
Cell viability was evaluated using the trypan blue staining method and cell concentration
estimated in a Neubauer-counting chamber by direct microscopy.
A macrophage (MΦ)-like cell line (P388D1, ATCC, Bird Park, Hawaii, USA) previously
isolated from a mouse lymphoma was expanded in RPMI-1640 (Lonza, Basel, Switzerland)
supplemented with 10% (v/v) of hiFBS, 2 mM L-glutamine (Merck) (complete RPMI
medium) at 37 ◦C in a humidified atmosphere with 5% CO2.
2.7. Stimulation of Macrophages and PBMC by TbEVs
MΦ (2 × 106 cells per well) and PBMC (1 × 105 cells per well) were plated in a sterile
96-well plate with complete RPMI medium and separately exposed to viable parasites
(3 parasites per cell) and stimulated with TbEVs (10 µg·mL−1). PBMC also was stimulated
by T. b. brucei soluble antigen (10 µg·mL−1). MΦ plates were incubated for 24 h and PBMC
plates for 72 h at 37 ◦C in a humidified atmosphere with 5% CO2. In parallel, unstimulated
cells, used as the negative control, and PMA (Promega, Madison, WI, USA) stimulated MΦ
and ConA (Sigma-Aldrich)-stimulated lymphocytes, used as the positive controls, were
also incubated.
2.8. Nitric Oxide and Urea Production by Macrophages
Supernatants of MΦ exposed to viable parasites, stimulated by TbEVs and PMA,
and non-stimulate (resting MΦ) were collected and used for quantification of urea by the
commercial kit QuantiChrom™ Urea Assay Kit-DIUR-100 (BioAssay System, Hayward,
CA, USA) and the indirect measurement of NO levels through the detection of NO2− and
NO3− using the Nitrate/Nitrite Colorimetric Assay (Abnova, Walnut, CA, USA). Both
assays were performed according to the manufacturer’s instructions.
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2.9. Macrophage and Lymphocyte Immunophenotyping
Cells (MΦ and PBMC) exposed to motile parasites and stimulated were harvested from
plates and washed with PBS. MΦ were labelled with mouse anti-MHCI (H-2Kb) monoclonal
antibody FITC directly conjugated and mouse anti-MHCII (I-A/I-E) monoclonal antibody
PE directly conjugated (BioLegend, San Diego, CA, USA).
PBMC were resuspended in PBS 0.5% hiFBS 2 mM EDTA and were added magnetic
microbeads coated with mouse anti-CD8a (Ly-2) monoclonal antibody (Miltenyi Biotec,
Bergisch Gladbach, Germany). Cells were incubated for 15 min at 4 ◦C protected from light
and then washed. CD8+ cells were sorted by positive selection, using a MACS® system
(Miltenyi Biotec) while CD8− cells were eluted.
Sorted CD8+ and CD8− cell fractions were washed with PBS 2% hiFBS 0.01% NaN3
and incubated for 30 min with mouse anti-CD3 monoclonal antibody FITC-directly conju-
gated and mouse anti-CD25 monoclonal antibody PerCP-cy5.5 directly conjugated (BioLe-
gend). After two washes in PBS, cell suspensions were fixed with PBS 2% formaldehyde.
Cells were then resuspended in permeabilization buffer (PBS 1% FBS, 0.1% NaN3, 0.5%
Triton-X, pH 7.4–7.6) and incubated for 20 min, washed and labelled with mouse anti-FoxP3
monoclonal antibody PE directly conjugated (BioLegend).
Cell acquisition was performed in a 4-colour flow cytometer (BD FACSCalibur, BD
Biosciences, USA) and data were analyzed using Flowjo V10 (Tree Star Inc., Ashland, OR,
USA). FSC-H vs. SSC-H gate was used to remove debris and pyknotic cells in the lower left
quadrant of the plot as well as the large (off-scale) debris found in the upper right quadrant.
Singlet gate was used to define the non-clumping cells based on pulse geometry FSC-H
vs. FSC-A, eliminating the doublets. CD3+, CD25+, and FoxP3+ cell subsets were defined
using fluorescence minus one control (FMOs).
To validate the composition of magnetically separated cell fractions, samples of un-
primed CD8+ and CD8− cell fractions were stained with the anti-CD3 monoclonal antibody
and anti-CD4 monoclonal antibody PerCp directly conjugated (BioLegend) and evaluated
by flow cytometry. In CD8+ cell fraction, less than 20% of cells presented a CD3+CD8−
phenotype, indicating that this cell fraction mainly was constituted by CD8+ T cells and
in the CD8− cell fraction ≈85% of the cells evidenced a CD3+CD4+ phenotype, which is
consistent with the predominance of CD4+ T cells.
2.10. Statistical Analysis
Data analysis was performed using GraphPad Prism version 8 (GraphPad Software,
San Diego, CA, USA). After verification by a Kolmogorov–Smirnov test that the data
of the current study do not evidence a normal distribution, significant differences were
determined using the non-parametric Wilcoxon matched-pair signed-rank test. A 5%
(p < 0.05) significance level was used to evaluate statistical significance. The surface and
perimeter of TbEVs are represented by violin plots (median, interquartile ranges and
distribution). Cell results of at least three independent experiments evaluated in triplicate
are expressed by whiskered box-plots, indicating the median, maximum and minimum
values or by graph bars (mean and standard error). The relative importance of TbEVs
in cell activity was assessed by the principal component analysis (PCA) of exploratory
multivariate statistical analysis, using Past4.03 (Natural History Museum, University of
Oslo, Oslo, Norway). PCA analysis organizes data in principal components, which can be
visualized graphically with a minimal loss of information, making visible the differences
between the activation of cells exposed to T. b. brucei parasites, TbEVs and Ag stimulated
cells. K-means cluster analysis also was used for cluster validation.
3. Results
3.1. T. b. brucei Trypomastigote Forms Release Extracellular Vesicles
Cultured-derived T. b. brucei parasites observed by direct microscopy and by scanning
electronic microscopy showed an elongated body, a flagellum (Figure 1A), and an undulat-
ing membrane (Figure 1B), which are recognised as the morphological characteristic of the
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trypomastigote form. Besides, cultured-derived parasite exhibited nanovesicles that seems
to bud from the cell surface and flagellum (Figure 2A,B).
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Figure 2. Release of extracellular nanovesicles by T. b. brucei and size and concentration of purified
TbEVs. Representative images (A,B) of culture-derived parasites shedding nanovesicles (arrowheads)
were acquired by SEM. TbEVs harvested from sup rnatants of T. b. brucei cultures were analyzed by
NTA (C). Mean values blue) + SD (red) are r presented by averag fi ite track l ngth adjus ment
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Suspension of purified nanovesicles derived from trypomastigote forms of T. b. brucei
evidenced a mean protein concentration of 5.107 µg·mL−1 (≈35.28) and NTA analysis
revealed that the size of TbEVs was within a range of 50 nm and 350 nm.
Two peaks of higher concentration of TbEVs with sizes around 100 and 170 nm were
detected, while TbEVs bigger than 200 nm seem to be rare (Figure 2C). The topographic
analysis place in evidence vesicles with a spherical shape and a smooth surface (Figure 3A),
with perimeter ranging between 335 and 3311 nm (mean 1634 nm ± 94.07) (Figure 3B)
and surface area between 9 and 872 nm (mean 255.2 nm ± 25.40) (Figure 3C). These data
also indicate that cultured-derived T. b. brucei parasites release two main classes of TbEVs:
small TbEVs (with perimeter and surface area around 65 nm and 905 nm, respectively) and
large TbEVs (with perimeter and surface area around 346 nm and 2088 nm, respectively).
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the GIMP2.10.0 software is shown. Perimet (B) and surface area (C) of TbEVs estimated by Image J r represent d by
violin plots, indicating median (thick blue bars), interquartile range (blue dots) and distribution.
3.2. T. b. brucei and TbEVs Induced Mouse MΦ to Produce NO and Urea
MΦ activity after stimulation with TbEVs was examined by the ability of cells to
metabolize arginine (Figure 4).
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Resting-MΦ incubated for 24 h (negative control) exhibited a residual NO synthesis
(Figure 4B). However, after PMA-stimulation (positive control), cells revealed a significant
NO increase (p = 0.0078), thus confirming the viability and functionality of these cells
that could transform arginase into NO through the enzymatic activity of NOS2. MΦ
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stimulated by TbEVs (p = 0.0313) or T. b. brucei parasites (p = 0.0078) (Figure 4A) showed
significant increases in NO levels when compared with resting MΦ. MΦ exposed to
parasites exhibited the higher NO production that was significantly different from TbEVs
exposed-MΦ (p = 0.0313).
In resting-MΦ were detected low levels of urea (Figure 4C). However, PMA stimulated
cells showed a significant increase in urea production (p = 0.0156), indicating that these
cells can convert arginine into urea through arginase enzymatic activity. MΦ stimulated by
TbEVs or exposed to parasites also exhibited significant high levels of urea when compared
with resting-MΦ (p = 0.0313).
Although both T. b. brucei parasites and TbEVs promote mouse MΦ to produce NO
and release urea, parasites elicit the highest secretion.
3.3. TbEVs Direct the Differentiation of MHCI+, MHCII+ and MHCI+MHCII+
Macrophage Subsets
To indirectly evaluate the possible presentation of parasite antigens by mouse MΦ, the
expression of MHC molecules by MΦ exposed to TbEVs for 24 h and the frequency of MHCI+
and MHCII+ MΦ subsets were analyzed by flow cytometry (Supplementary Figure S1 and
Figure 5).
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stimulated by TbEVs and PMA, and in resting-MΦ (negative control, NC). Results of at least three independent experiments
(n = 32) and at two replicates per sample are represented by whisker box-plot, median, minimum, and maximum values.
The non-parametric Wilcoxon matched-pairs signed-rank test was used for statistical comparisons. * (p < 0.05), ** (p < 0.01),
*** (p < 0.001), and **** (p < 0.0001) indicate st tistically sig ificant values.
A significant high frequency of MHCI+ (Figure 5A), MHCII+ (p = 0.0001) (Figure 5B),
and MHCI+MHCII+ Φ (p = 0.0313) was observed in cells stimulated by PMA (Figure 5C)
when compared with resting cells. MHCI+ MΦ (p = 0.01) and MHCII+ MΦ (p = 0.0039)
subsets were inhibited after T. b. brucei exposure. On the other hand, TbEVs elicited
a significantly high expression of MHCI+ (p = 0.0003) and MHCII+ MΦ (p = 0.0004) in
comparison to resting cells and cells exposed to parasites (p MHCI+ Φ <0.0001, p MHCII+
MΦ = 0.0039).
TbEVs seemed to be responsible for a significative expansion of MHCI+MHCII+ MΦ
subset (p = 0.0313) (Figure 5C). Also, in this case, the exposure to parasites caused a
significant reduction of this cell subpopulation when comparing with resting-MΦ and
TbEVs stimulated MΦ (p = 0.0313).
When analyzing the levels of fluorescence intensity, no differences were observed
between resting-MΦ, MΦ exposed to parasites and TbEVS stimulated MΦ. Only PMA-
stimulated MΦ evidence a considerable augment of MHCI (p = 0.0313).
Altogether the results indicated that TbEVs enhance the expression of MHCII class I
and class II in MΦ, favouring antigen presentation, but did not increase the surface density
of these molecules on the cell surface. On the other hand, T. b. brucei parasites promote
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a reduction of MHCI+, MHCII+ and MHCI+MHCII+ MΦ subsets, possible avoiding the
antigen presentation and activation of cytotoxic and helper T cells.
3.4. TbEVs Promoted Specific Mouse Macrophage Activation
To identify correlations between the influence of TbEVs and T. b. brucei parasites
on mouse MΦ, data were analysed by PCA. This statistical analysis indicated that the
overall influence of TbEVs and PMA on MΦ activity is correlated (Figure 6A). On contrary,
T. b. brucei effects on mouse MΦ were distinct from TbEVs and resting-MΦ. These results
were confirmed by cluster analysis, which aggregates in the same cluster (cluster 3) the
effects of TbEVs and PMA on MΦ. MΦ activity caused by parasite exposure was found
through clusters 2 and 3, with most of the effects in cluster 2 whereas resting-MΦ is mainly
localized in cluster 1 (Figure 6B).
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Therefore, this analysis highlights that TbEVs activation of rodent MΦ can be different
from cell activation induced by T. b. brucei.
3.5. TbEVs Favored the Differentiation of CD4+ T Cells and Increment the Surface Expression of
CD3 Molecules
The frequency of CD3+ cells (Figure 7) and expression level of CD3 molecules were
examined in mononuclear blood cells exposed to parasites or stimulated by TbEVs or
parasite Ag (Supplementary Figure S2).
In both CD4+ (Figure 7A) and CD8+ (Figure 7B) cell fractions, the frequency of CD3+
cells were significantly lower in cells exposed to T. b. brucei in comparison to unprimed
cells (p = 0.0078). However, ConA stimulation caused a significant increase in CD3+
cells in both cell fractions (p = 0.0078). In both cell fractions, cells exposed to parasites
were also statistically different from TbEVs and Ag stimulated cells (p = 0.0313). TbEVs
were responsible for a significant increase of CD3+ cell subset in the CD4+ cell fraction
(p = 0.0078) in comparison with unprimed and parasite exposed cells.
The fluorescence intensity of CD3-labelled cells in both cell fractions significantly
increased (p = 0.0313) in Ag and TbEVs stimulated PBMC when compared to unprimed cells.
Stimulation by ConA also induced a significant increase (p = 0.0313) in CD3-fluorescence
intensity of CD4+ cell fraction. On the other hand, when compared to unprimed cells
and TbEVs and Ag-stimulated cells, exposure to T. b. brucei cultured-derived parasites
weakened CD3 fluorescence in CD4+ and CD8+ cell fractions (p = 0.0313).
Altogether, these results indicated that TbEVs stimulation seemed to trigger the
expansion of the CD4+ (CD3hi) T cell subset and induce the expression of CD3 molecules
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on CD8+ T cells. In contrast, T. b. brucei parasites impaired the differentiation of CD8+ and
CD4+ T cells and promoted the down expression of CD3 molecules at the cell surface.
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3.6. TbEVs Led the Expansion of Regulatory CD4+ T Cells and FoxP3+CD4+ T Cell Subset and
Enhanced Surface CD25+ and Intracellular FoxP3+ Molecules
To assess the effect of TbEVs on CD4+ and CD8+ T cell subsets, mononuclear blood
cells were exposed to cultured parasites and stimulated by TbEVs or parasite Ag. The
frequency of CD4+ T cells expressing CD25 (Figure 8) molecules was evaluated as well as
the density of CD25 molecules on the cell surface and intracellular FoxP3 molecules on
stimulated cells. Since parasite-exposed cells evidence a low frequency of CD3+ cells only
expression and density CD25 were examined.
T. b. brucei parasites induced a significant expansion of the CD4+ T cell subset ex-
pressing CD25 comparing to unprimed cells, TbEVs, and Ag stimulated cells (p = 0.0313)
(Figure 8C). Parasite Ag and TbEVs caused a high expansion of FoxP3+ CD4+ (Figure 8D)
and FoxP3+CD25+ CD4+ T cells (p = 0.0313) (Figure 8A) in comparison to unprimed cells.
Stimulation of PBMC by ConA led to a significant expansion (p = 0.0313) of CD4+ T
cell subset (Figure 8B). On the other hand, parasites, TbEVs or Ag did not seem to affect
the CD4+ (FoxP3− CD25−) T cell subset.
TbEVs and parasites promoted a higher fluorescence intensity of CD25-labeled cells
when compared with unprimed lymphocytes (p = 0.0313). Furthermore, T. b. brucei
parasites induced a higher expression of CD25 molecules in comparison to TbEVs and Ag
stimulated cells (p = 0.0313). Significant ov rexpression of intracellular FoxP3 molecules
was also found in CD4+ T cells aft r stimulation with TbEVs or Ag (p = 0.0331).
These results indic ted that TbEVs and parasite Ag favoured exp nsion of regulatory
CD4+ T cell subset (FoxP3+CD25+CD3+ CD4+, T reg cells) and FoxP3+CD4+ T cells. More-
over, T. b. brucei parasites enhanced the frequency of CD25+CD4+ T cells. Among CD4+ T
cells, the overexpression of α-chai of IL2-receptor (CD25) was nduced by parasites and
TbEVs, and the increased expression of FoxP3 was licited by TbEVs and Ag.
3.7. TbEVs Direct the Expansion of Effector CD8+ T Cells and CD8+ T Cells Expressing FoxP3+
Phenotype and Increase Surface CD25 and Intracellular FoxP3 Molecules
CD8+ T cell subsets were examined by estimating the frequency of CD8+ T cells
expressing CD25 in mononuclear blood cells exposed to parasites and stimulated by
TbEVs or parasite Ag (Figure 9). The expression of FoxP3 was evaluated in stimulated
cells. Furthermore, the potential of these cells to recognize IL-2 and regulate the cell
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immune activity was indirectly assessed by the density of surface CD25 and intracellular
FoxP3 molecules.
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box-plot, median, minimum, and maximu values. The non-parametric Wilcoxon matched-pair signed-rank test was used
for statistical comparisons. * (p < 0.05) indicated significant differences.
When compared to unprimed CD3+CD8+ cells, it was observed that ConA stimu-
lation caused a significant high frequency of CD8+ T cell subsets expressing CD25+ and
FoxP3+ (p CD25+ FoxP3+ = 0.0313, Figur 9A; p CD25+ = 0.0078, Figure 9C) as well as CD8+
(CD25−FoxP3−) T cells (p = 0.0516, Figure 9B). Cells stimulated by TbEVs (p = 0.0156)
showed significant high frequencies of CD25+FoxP3+CD8+ T cells (Figure 9A).
TbEVs and Ag induced a significant expansion of CD8+ (CD25−FoxP3−) T cell subset
(p = 0.0156) and promoted the retraction f CD25−FoxP3+ CD8+ T cell subset (p = 0.0313)
(Figure 9B). However, when compared to unprimed cells, T. b. brucei parasites caused a
significant restrain of CD8+T cells.
CD8+ T cells exposed to T. b. brucei parasites or stimulated by ConA, TbEVs, and
parasite Ag showed a significant increase of CD25 molecules (p = 0.0313) when comparing
with unprimed cells. Furthermore, FoxP3 fluorescent intensity also increased in CD8+T
cells stimulated by TbEVs (p = 0.0313).
Altogether the results indicated that TbEVs mainly triggered the expansion of effector
CD8+T cells and CD8+ T cell subsets expressing FoxP3 associated with a higher density
Biomedicines 2021, 9, 1056 12 of 17
of FoxP3 molecules. The overexpression of α-chain of IL2-receptor (CD25) induced by
parasites can be mainly associated with the expansion of CD25+ CD8+ T cell subset.
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3.8. TbEVs and Parasite Ag Triggered Related Influence on the Phenotype of BALB/c Mice T Cells
PCA analysis of CD4+ and CD8+ T cells indicated a positive correlation between the
effect of TbEVs and parasite Ag on T cells (Figure 10A), which contrasted with T. b. brucei
effects. These results were confirmed by cluster analysis, which showed the effects of Ag
and TbEVs grouped in cluster 3. On the other hand, the influence of parasites in T cells was
grouped at cluster 1. Furthermore, ConA stimulation outcomes were localized in cluster
2 and the intrinsic activity of unprimed T cells were mainly within cluster 3 (Figure 10B).
Overall, the effect of TbEVs on BALB/c mice T cells seemed to be similar to cell stimulation
caused by parasite Ag and slightly different of unprimed cells, but completely different
from T. b. brucei parasites.
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the hemolymphatic phase. Therefor , a balance between inf ction level (parasitemia)
and the intensity of the inflammatory immune response st be achiev d in the host. Since
safe and efficient anti-trypanosomal drugs and vaccines are lacki g, many are the studies
perform d to understand the mechanisms associated wit the host immun response direct
against T. brucei infection. Although different approac es were applied, and numerous
findings reported, some questions remain unanswered, and some mechanisms are not
entirely understood or still controversial.
Since EVs released by eucaryotic cells seem to play a role in intercellular communi-
cation, interfering with several cellular processes, such as the activation of microbicide
processes and generation of immune mediators by changing gene expression and affecting
signalling pathways the potential of trypomastigotes derived EVs in influencing the im-
mune activity of innate and adaptive immune cells was explored. Findings of the current
study indicate that TbEVs shed by trypomastigotes is enriched in proteins and are a het-
erogeneous population of spherical vesicles mainly constituted by smaller (<0.17 nm) and
biggest (>0.17 nm) EVs, which is in line with previous findings [12].
Since the expansion in different organs and tissues of the MΦ population, as is the
case of the liver, spleen, and the bone marrow was described in T. brucei infected mice, the
intercommunication of TbEVs with innate immune cells were examined. It is reported that
inducible nitric oxide synthase (iNOS) peaked six days post-infection and that oxidized
L-arginine generates L-citrulline and NO [15]. In the current study, TbEVs trigger mouse
MΦ to produce NO as well as T. brucei cultured parasites, suggesting a role for TbEVs at
the early stage of sleeping sickness. NO is a highly regulated effector molecule, which
participates in several physiological and immune processes and can inactivate pathogens
including T. brucei parasites [15]. However, high NO levels can be a disadvantage to the
host, given the large spectra of cell disorders that are associated with NO activity. In
sleeping sickness, the persistence of M1-MΦ is related to anaemia and systemic immune
response [16–19].
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To counteract the possible harmful effect of NO in the host and perpetuate parasite
replication, African trypanosomes induce the differentiation of M2-MΦ. L-Arginine can
be hydrolyzed by arginase, generating ornithine, urea, proline and polyamines [20]. A
previous study performed in T. b. brucei-infected mice indicates that M1-MΦ predominate
in the early stage of infection while M2-MΦ prevail at a later infection stage (1–4 weeks) [18].
In the current study was found that TbEVs and cultured parasites induced urea and NO
production by mouse MΦ. These findings reinforce the role of TbEVs in the early stage of
infection as a MΦ modulator. By inducing the differentiation of mouse MΦ expressing M1
and M2 phenotypes, TbEVs seem to strengthen parasite activity in sustaining a balance
between pro-inflammatory and anti-inflammatory responses. Moreover, by simultaneously
ensuring the supported production of polyamines, which are essential nutrients for parasite
survival and replication [7,21], TbEVs can facilitate the establishment of a chronic infection.
The kinesin-1 heavy chain (TbKHC-1) released by African trypanosomes has been described
as an activator of the arginine pathway, leading to the production of polyamines [7]. Taking
into account the above considerations, TbKHC-1 may form part of TbEVs’ cargo.
Contrary to T. b. brucei parasites that cause a marked reduction in the frequency of
MHCI+ and MHCII+ MΦ, affecting the recognition of parasite antigens by T lymphocytes
and compromising the adaptive immune response, TbEVs induce differentiation of MHCI+
and MHCII+ MΦ and double-positive MΦ (MHCI+ MHCII+), indicating that these cells
can establish a link with acquired immunity by presenting parasite antigens to helper and
cytotoxic T cells. Even so, the density of MHCI and MHCII molecules on the membrane
surface of MΦ remained similar to resting MΦ. Though not fully understood similar
inhibition of MHC expression avoiding antigen presentation was mentioned in a study
carried out on T. cruzi, which is an intracellular parasite responsible for Chagas’ disease or
American trypanosomiasis [22]. Therefore, TbEVs that appear to exert an action contrary
to the parasite may cause the activation of adaptive immunity at least to some point,
activating both CD4+ and CD8+ T cells.
During the course of infection, T. brucei releases the stumpy induction factor (TSIF)
that has been associated with the impairment of T cell proliferation [23]. A previous study
performed in patients infected with T. b. gambiense has shown that T cells were considerably
lower when compared with controls [24]. Thus, considering the high importance of cellular
activation in orchestrating an integrated host immune response against sleeping sickness,
the communication established by TbEVs on T cell expansion was also examined. In agree-
ment with previous findings, a marked reduction of both CD3+CD4+ and CD3+CD8+ T
cells caused by T. b. brucei parasites was found in the current study. However, TbEVs favour
the expansion of CD4+ T cell subpopulation and induce the increase of CD3 expression in
both CD4+ and CD8+ subsets (CD3hi CD4+ and CD3hi CD8+ T cells). CD3 complex is a T
cell co-receptor responsible for intracellular signalling. Altogether, these findings indicate
that, contrary to T. b. brucei, TbEVs may have the necessary conditions to stimulate T cells.
However, in a previous study, Boda and colleagues [25] reported that effector CD8+ T
cells were significantly lower in patients with African trypanosomiasis which corroborates
our findings.
In the current study, T. b. brucei parasites induce the expansion of CD4+ and CD8+
T cell subpopulations expressing a CD25 phenotype and favour the expression of CD25
molecules (CD25hiCD4+ and CD25hiCD8+ T cells). CD25 is the α chain of the IL-2 receptor,
which is expressed by regulatory T (Treg) cells. CD25 is required for interleukin (IL)-2
signalling that mediates T cell activation and proliferation. To become fully activated, CD8+
T cells require the help of CD4+ T cells mediated by IL-2. However, Kalia et al. [26] have
found that CD25hiCD8+ T cells can perceive proliferation signals (IL-2) and differentiate
into short-lived effector cells and Olson et al. [27] reported that lymphocyte triggering
factor (TLTF) released by T. b. brucei specifically elicit CD8+ T cells to generate IFN-γ.
Moreover, it was reported that activated CD4+ T cells secrete IFN-γ and is recognised that
this cytokine functions as a T. b. brucei growth factor [28]. Thus, T. b. brucei parasites may
favour the expansion of CD25+ T cells to ensure their survival.
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FoxP3 nuclear factor is a regulator of gene expression that suppresses the function of
NFAT and NF-κB nuclear factors, avoiding the expression of pro-inflammatory cytokine
genes, including IL-2. CD4+ Treg cells which constitutively express FoxP3 can suppress
leukocyte effector activity, contributing to the maintenance of immune homeostasis. These
regulatory cells also exhibit a high expression of CD25 molecules. In African trypanosomia-
sis, the expansion of Treg cells seems to occur from the parasite establishment to the chronic
stage, being associated with parasite tolerance (reviewed in [29]) and in trypanotolerant
C57BL/6 mice, the expansion of CD25+ FoxP3+ CD4+ T cell subset was demonstrated after
the first peak of parasitemia [30]. On the other hand, the lack of expansion of Treg cells is
associated with tissue damage and impaired survival of infected mice [31]. In the current
study, TbEVs promote the expansion of CD4+ and CD8+ Treg cells and FoxP3+ CD4+ T
cell subset. According to Zelenay et al. [32], CD4+ T cells expressing FoxP3+ phenotype
are committed Treg cells able to regain CD25 expression. Thus, TbEVs seem to induce
the differentiation of CD4+ and CD8+ Treg cells and unconventional CD4+ Treg cells. In
previous studies, it was reported that unconventional-Treg cells also can exert regulatory
functions [33]. During chronic parasite infection, uncontrolled inflammation is one of the
most clinical features noticed that can become lethal if not controlled by Treg cells [34,35].
Therefore, during infection TbEVs can lead to the establishment of a pool of T cells with a
regulatory phenotype able to balance excessive inflammation.
Altogether, these findings indicate that T. b. brucei parasites can activate the me-
tabolization of arginine by MΦ and [36] modulate T cells, ensuring the production of
polyamines and IFN-γ, both critical for parasite survival. At the same time, this parasite
avoids antigen presentation by MΦ and T cells activation.
However, the findings of the present study place in evidence that TbEVs can establish
direct communication with cells of innate and adaptive immunity, and the effect of TbEVs
on these cells is different from the parasite itself. TbEVs can elicit parasite antigenic presen-
tation to CD4+ and CD8+ T cells possible leading to the activation of the cellular immune
response in addition to the bidirectional activation of mouse MΦ, contributing to the release
of factors essential to parasite growth and, also, to parasite destruction. Moreover, TbEVs
also seems to have a direct effect on CD4+ T lymphocytes, triggering the expression of T
cell co-receptors, which are key players in intracellular signalling. The expression of the
nuclear factor FoxP3 was also stimulated by TbEVs, guiding the differentiation of CD4+
and CD8+ Treg cells. imposing regulation on host inflammatory immune response which
is a hallmark of sleeping sickness. Since an unbalanced inflammatory response against the
parasite can become lethal to the host, the role of Treg cells in protecting from collateral
tissue damage is crucial. On the other hand, TbEVs induced the differentiation of effector
CD8+ T cells and drive the overexpression of FoxP3 molecules in CD4+ T cells which
are involved in maintaining immune homeostasis. Therefore, parasites and TbEVs seem
to display complementary effects in the host immune response that can ensure parasite
survival, delaying disease severity and the eventual death of the host. Furthermore, TbEVs
represent a source of biomarkers that can open new avenues for a better diagnosis of
sleeping sickness and the development of prophylactic measures to control the disease
caused by T. brucei in Subsaharan Africa.
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